It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...

Otulfi ® is an ustekinumab biosimilar for the reference product Stelara ® (ustekinumab ... in patients with a chronic infection or a history of recurrent infection. Instruct patients to seek medical ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...

In a cohort of more than 11,000 patients from the U.K. and Ireland, a comparable proportion of new adalimumab users achieved ...

Otulfi® is an ustekinumab biosimilar for the reference product ... in patients with a chronic infection or a history of recurrent infection. Instruct patients to seek medical advice if signs ...

Biosimilars for adalimumab have been on the ... The new user analysis included those with moderate to severe psoriasis with no history of adalimumab, 5,416 starting Humira, 382 starting Amjevita ...

Biosimilars like SELARSDI provide cost-saving ... initiating use of SELARSDI in patients with a chronic infection or a history of recurrent infection. Instruct patients to seek medical advice ...

PYZCHIVA becomes Samsung Bioepis’ fifth biosimilar and third immunology ... of PYZCHIVA in patients with a chronic infection or a history of recurrent infection. Instruct patients to seek ...

“Biosimilars like SELARSDI create opportunities ... initiating use of SELARSDI in patients with a chronic infection or a history of recurrent infection. Instruct patients to seek medical advice ...